Markt für High-Flow-Nasenkanülen im asiatisch-pazifischen Raum bis 2027 – regionale Analyse und Prognosen nach Komponenten (Luftsauerstoffmischer, Nasenkanüle, beheizter Inspirationskreislauf und aktiver Luftbefeuchter); Anwendung (Bronchiektasen, akute Ateminsuffizienz, akute Herzinsuffizienz und chronisch obstruktive Lungenerkrankung); Endbenutzer (Ambulante Pflegezentren, Krankenhäuser und Langzeitpflegezentren) und Land
Der Markt für High-Flow-Nasenkanülen im asiatisch-pazifischen Raum wird voraussichtlich
2.536,52 Mio. US-Dollar erreichen im Jahr 2027 von 951,53 Mio. p>
Die Schlüsselfaktoren, die das Wachstum des Marktes für High-Flow-Nasenkanülen vorantreiben, sind die wachsende ältere Bevölkerung und die zunehmenden chronischen Atemwegserkrankungen in der gesamten APAC-Region. Die Faktoren, die das Marktwachstum hemmen, sind jedoch Nachwirkungen im Zusammenhang mit High-Flow-Nasenkanülen.
Nach Angaben der NCD Alliance chronisch respiratorische Erkrankungen Erkrankungen (CRDs) beschreiben eine Reihe von Erkrankungen der Atemwege und anderer Strukturen der Lunge. Dazu gehören Asthma und Atemwegsallergien, berufsbedingte Lungenerkrankungen, chronisch obstruktive Lungenerkrankung (COPD), Schlafapnoe-Syndrom und pulmonale Hypertonie. Die Belastung durch chronische Atemwegserkrankungen (CRDs) nimmt in allen Ländern im asiatisch-pazifischen Raum zu. Laut dem in The Lancet Global Health veröffentlichten Artikel leben in Indien 18 % der Weltbevölkerung und eine zunehmende Belastung durch chronische Atemwegserkrankungen.
Die Prävalenz von Asthma in Indien ist im Vergleich zu anderen Ländern deutlich hoch. Mit geschätzten 15 bis 20 Millionen Asthmapatienten lebt mindestens jeder zehnte Asthmapatient in Indien. Nach Schätzungen der WHO leiden rund 30 Millionen Inder an Asthma. Zu den häufigsten Faktoren für den Anstieg der Asthmafälle in Indien gehören unter anderem Fettleibigkeit, Rauchen, Luftverschmutzung im Innen- und Außenbereich, plötzlicher übermäßiger oder falscher Gebrauch von Antibiotika, Pollen, Passivrauchen, schlecht belüftete Wohnungen und Arbeitsplätze . Abgesehen von Asthma geben auch die steigenden COPD-Fälle im Land Anlass zur Sorge. Laut der Global Burden of Disease-Studie der University of Washington aus dem Jahr 2018 war COPD die zweithöchste Todesursache in Indien und führte zum Tod von fast 958.000.
< /p>
Umsatz und Prognosen für den Markt für High-Flow-Nasenkanülen in Indien bis 2027 (Mio. USD)
Europa-Markt für High-Flow-Nasenkanülen – Nach Komponente
Luftsauerstoffmischer
Nasenkanüle
Beheizter Inspirationskreislauf
Aktiver Luftbefeuchter
Europa High-Flow Markt für Nasenkanülen – Nach Anwendung
Bronchiektasie
Akutes Atemversagen
< li>Akute Herzinsuffizienz
Chronisch obstruktive Lungenerkrankung (COPD)
Europa-Markt für High-Flow-Nasenkanülen – Nach Endbenutzer
Strategic insights for Asia-Pacific High-Flow Nasal Cannula involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
The regional scope of Asia-Pacific High-Flow Nasal Cannula refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Asia-Pacific High-Flow Nasal Cannula Market
The List of Companies - APAC High Flow Nasal Cannula Market
Great Group Medical Co., Ltd.
Salter Labs
Fisher And Paykel Healthcare Limited
TNI Medical Ag
Mek-Ics Co., Ltd.
Flexicare Medical Limited
Vapotherm
Teleflex Incorporated
Resmed
Hamilton Medical Inc,
Frequently Asked Questions
How big is the Asia-Pacific High-Flow Nasal Cannula Market?
The Asia-Pacific High-Flow Nasal Cannula Market is valued at US$ 951.53 Million in 2018, it is projected to reach US$ 2,536.52 Million by 2027.
What is the CAGR for Asia-Pacific High-Flow Nasal Cannula Market by (2019 - 2027)?
As per our report Asia-Pacific High-Flow Nasal Cannula Market, the market size is valued at US$ 951.53 Million in 2018, projecting it to reach US$ 2,536.52 Million by 2027. This translates to a CAGR of approximately 11.7% during the forecast period.
What segments are covered in this report?
The Asia-Pacific High-Flow Nasal Cannula Market report typically cover these key segments-
Endbenutzer (Ambulante Pflegezentren, Krankenhäuser und Langzeitpflegezentren)
What is the historic period, base year, and forecast period taken for Asia-Pacific High-Flow Nasal Cannula Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific High-Flow Nasal Cannula Market report:
Historic Period : 2016-2017
Base Year : 2018
Forecast Period : 2019-2027
Who are the major players in Asia-Pacific High-Flow Nasal Cannula Market?
The Asia-Pacific High-Flow Nasal Cannula Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Great Group Medical Co., Ltd.
Salter Labs
Fisher And Paykel Healthcare Limited
TNI Medical Ag
Mek-Ics Co., Ltd.
Flexicare Medical Limited
Vapotherm
Teleflex Incorporated
Resmed
Hamilton Medical Inc,
Who should buy this report?
The Asia-Pacific High-Flow Nasal Cannula Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Asia-Pacific High-Flow Nasal Cannula Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Asia-Pacific High-Flow Nasal Cannula Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines
Get Free Sample For Asia-Pacific High-Flow Nasal Cannula Market
